DETECT – Advances in The Delayed-Onset of Type 1 Diabetes: Strategies to Improve Awareness and Care for The Practicing Clinician

Thursday, September 19, 2024

6:00 PM CT – 6:30 PM CT – Dinner & Registration
6:30 PM CT – 8:00 PM CT – CME Meeting

The Westin Houston Medical Center/Museum District
1709 Dryden Road
Houston, TX, 77030,
Meeting Room: Azure 1 & 2


    • Downloadable whiteboard animations
    • Interactive, case-based learning environment
    • Create-your-own personalized poster


Kimber Simmons, MD, MPH
Associate Professor of Pediatrics
Barbara Davis Center for Diabetes
University of Colorado
Anschutz Medical Campus
Aurora, CO
Chuck Vega, MD, FAAFP
Health Sciences Clinical Professor
UC Irvine Department of Family Medicine
Director, UCI Program in Medical Education for the Latino Community
Irvine, CA


The DETECT T1D Live Summit series has been designed to enable clinicians to help improve the screening and early detection of type 1 diabetes (T1D), as well as be on the forefront of therapeutic advances that delay T1D progression. Led by renowned experts, the series will utilize interactive case-based discussions and high-impact animations to better highlight these advances and provide practical tools and strategies for screening, follow-up, and treatment of early-stage T1D.


This activity is designed to meet the educational needs of Pediatric and Adult Endocrinologists, Pediatricians, Primary Care Providers and Endocrine Nurses. Additionally, accessible programming and tools have been designed for patients, relatives, and members of the general population. As discussed within program descriptions, activities are designed in a manner that allows learners to choose programming most relevant to their professional needs.


Upon completion of this activity, HCPs will have improved ability to:

  • Describe the clinical presentation of T1D in adults compared to children
  • Identify appropriate autoantibody screening strategies for T1D, including type, frequency, and number
  • Interpret results from screening protocols to drive management decisions
  • Discuss the latest clinical evidence for efficacy and tolerability of newly approved and investigational immunomodulatory agents
  • Implement strategies for appropriate clinical monitoring and early screening in individuals at highest risk


In support of improving patient care, Med Learning Group is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.


Med Learning Group designates this virtually live activity for a maximum of 1.5 AMA PRA Category 1 CreditsTM. Physicians should claim only the credit commensurate with the extent of their participation in the virtually live activity.


Med Learning Group designates this activity for a maximum of up to 1.5 ANCC contact hours.


Med Learning Group designates this activity for a maximum of 1.5 CPEU.


Med Learning Group designates this activity for a maximum of up to 1.5 knowledge-based CPE contact hours.

NOTE to Pharmacists: The only official Statement of Credit is the one you pull from CPE Monitor. You must request your certificate within 45 days of your participation in the activity to meet the deadline for submission to CPE Monitor. Credits are generally reported during the first week of each month for those who claimed during the month prior.


In accordance with the Accreditation Council for Continuing Medical Education (ACCME) Standards for Integrity and Independence in Accredited Continuing Education, educational programs sponsored by Med Learning Group must demonstrate balance, independence, objectivity, and scientific rigor. All faculty, authors, editors, staff, and planning committee members participating in an MLG-sponsored activity are required to disclose any relevant financial interest or other relationship with the manufacturer(s) of any commercial product(s) and/or provider(s) of commercial services that are discussed in an educational activity.


Med Learning Group requires that faculty participating in any CE activity disclose to the audience when discussing any unlabeled or investigational use of any commercial product or device not yet approved for use in the United States.

During this lecture, the faculty may mention the use of medications for both FDA-approved and non-approved indications.


Med Learning Group makes every effort to develop CE activities that are science based. This activity is designed for educational purposes. Participants have a responsibility to use this information to enhance their professional development in an effort to improve patient outcomes. Conclusions drawn by the participants should be derived from careful consideration of all available scientific information. The participant should use his/her clinical judgment, knowledge, experience, and diagnostic decision-making expertise before applying any information, whether provided here or by others, for any professional use.

For CE questions, please contact Med Learning Group at [email protected]

Contact this CE provider at Med Learning Group for privacy and confidentiality policy statement information at


Event Staff will be glad to assist you with any special needs (eg, physical, dietary, etc).  Please contact Med Learning Group prior to the live event at [email protected]

Scroll to Top

A Special Thank You to All HCPs

Med Learning Group sends its heartful gratitude to all healthcare professionals giving their all, 24/7, during this pandemic, despite the great risks they face. We cannot thank you enough for your courage and selfless service.

Connecting you with our personalized approach to continuing Medical Education

Healthcare Business Review Award

We are thrilled to announce that we have been recognized as one of the Top 10 Health Education Services Providers by Healthcare Business Review!

This award is both an honor and a testament to our cumulative dedication to providing the best continuing medical education (CME) services to HCPs across the globe. We are proud to be part of this distinguished group and look forward to continuing to have MLG be one of the best CME providers in the country.

Thank you to Healthcare Business Review for this recognition and for shining a light on the importance of accurate and accessible healthcare education.

#TopHealthEducationProvider #MedLearningGroup #HealthcareBusinessReview #MedicalEducation

Best of America Small Business Awards
Best Website

The Best of America Small Business Website award recognizes the best website launched by a small business since 2021. Technology is a key growth enabler for small businesses. The best in tech track recognizes small businesses as experts in technology and innovation from innovators, app developers, and website creators. Visit our award-winning Ophthalmology and Optometry web portal:

The Linking Approach to Education from Gap Analysis to Outcomes

Med Learning Group, a division of Ultimate Medical Academy, is a full-service accredited medical education company with commendation. Med Learning Group focuses on developing and implementing continuing education that improves healthcare practitioners’ ability to provide optimal care to their patients. Our goal is to provide high-quality education that is designed to deliver the highest level of outcomes for not only the practitioner, but also the patient. Med Learning Group has expertise in developing both live and online activities that are innovative, case-based, interactive and patient-centric in nature.

Med Learning Group has expertise in developing both live and online activities that are innovative, case-based, interactive and patient-centric in nature, and we focus on applying adult learning theory and principles to our programs. Even more importantly, we understand the nuances of our target audiences and design programs with a grounded understanding of how to educate both specialty audiences and general practitioners.